Article ; Online: Obesity-induced endothelial dysfunction is prevented by deficiency of P-selectin glycoprotein ligand-1.
2012 Volume 61, Issue 12, Page(s) 3219–3227
Abstract: ... the cardiovascular complications triggered by obesity. We tested the hypothesis that deficiency of P-selectin ...
Abstract | Endothelial dysfunction precedes atherosclerosis and represents an important link between obesity and cardiovascular events. Strategies designed to prevent endothelial dysfunction may therefore reduce the cardiovascular complications triggered by obesity. We tested the hypothesis that deficiency of P-selectin glycoprotein ligand-1 (Psgl-1) would improve the endothelial dysfunction associated with obesity. Psgl-1-deficient (Psgl-1(-/-)) and wild-type (Psgl-1(+/+)) mice were fed standard chow or a high-fat, high-sucrose diet (diet-induced obesity [DIO]) for 10 weeks. DIO increased mesenteric perivascular adipose tissue (mPVAT) macrophage content and vascular oxidative stress in Psgl-1(+/+) mice but not in Psgl-1(-/-) mice. Pressure myography using mesenteric arteries demonstrated that relaxation responses to acetylcholine were significantly impaired in DIO Psgl-1(+/+) mice, whereas DIO Psgl-1(-/-) mice were protected from endothelial dysfunction with similar relaxation responses to Psgl-1(+/+) or Psgl-1(-/-) mice fed standard chow. The superoxide scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy (TEMPOL) partially recovered impaired endothelial function induced by DIO. A neutralizing Psgl-1 antibody was also effective in preventing endothelial dysfunction and reducing mPVAT macrophage content induced by DIO. These results indicate that obesity in mice leads to PVAT inflammation and endothelial dysfunction that is prevented by Psgl-1 deficiency. Psgl-1 inhibition may be a useful treatment strategy for targeting vascular disease associated with obesity. |
---|---|
MeSH term(s) | Animals ; Antioxidants/therapeutic use ; Cyclic N-Oxides/therapeutic use ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/physiopathology ; Immunoblotting ; Immunohistochemistry ; Male ; Membrane Glycoproteins/therapeutic use ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Obesity/drug therapy ; Obesity/physiopathology ; Real-Time Polymerase Chain Reaction ; Spin Labels ; Vascular Diseases/metabolism ; Vascular Diseases/prevention & control |
Chemical Substances | Antioxidants ; Cyclic N-Oxides ; Membrane Glycoproteins ; P-selectin ligand protein ; Spin Labels ; tempol (U78ZX2F65X) |
Language | English |
Publishing date | 2012-08-13 |
Publishing country | United States |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. |
ZDB-ID | 80085-5 |
ISSN | 1939-327X ; 0012-1797 |
ISSN (online) | 1939-327X |
ISSN | 0012-1797 |
DOI | 10.2337/db12-0162 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.175: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.